Bayforest Capital LTD Novavax Inc Transaction History
Bayforest Capital LTD
- $134 Billion
- Q4 2025
A detailed history of Bayforest Capital LTD transactions in Novavax Inc stock. As of the latest transaction made, Bayforest Capital LTD holds 14,318 shares of NVAX stock, worth $99,796. This represents 0.07% of its overall portfolio holdings.
Number of Shares
14,318Holding current value
$99,796% of portfolio
0.07%Shares
3 transactions
Others Institutions Holding NVAX
# of Institutions
307Shares Held
98.4MCall Options Held
5.7MPut Options Held
9.06M-
Vanguard Group Inc Valley Forge, PA15.5MShares$108 Million0.0% of portfolio
-
Shah Capital Management14.6MShares$101 Million48.17% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$82.6 Million0.0% of portfolio
-
State Street Corp Boston, MA7.2MShares$50.2 Million0.0% of portfolio
-
Ubs Group Ag4.89MShares$34.1 Million0.01% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $545M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...